Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8003223 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL9460784 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL28515810 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL31498965 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL28522527 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL25342942 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL11267960 | 0.94 | NAAA (0.46) | NAAAEPHX1TSHRMEN1MAPT | |
| SCHEMBL1734681 | 0.93 | NAAA (0.48) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL28823876 | 0.92 | ALDH1A1 (0.47) | NAAAEPHX1TSHRHCAR2MEN1 | |
| SCHEMBL8416067 | 0.88 | NAAA (0.44) | NAAAEPHX1TSHRHCAR2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117042748-A | Inverse emulsion comprising at least one fatty alcohol, a nonionic sugar ester, ethylcellulose, and a method employing the inverse emulsion | 莱雅公司 | 2023-11-10 | — | — | CN | claimed |
| CN-105848725-B | Transfer device for making up keratin materials | 欧莱雅 | 2021-11-12 | — | — | CN | claimed |
| CN-113041171-B | Moisturizing composition containing hyaluronic acid | 上海家化联合股份有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-108136219-B | Stable dispersions containing droplets comprising gellant | 卡普苏姆公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118059020-A | Composition with moisturizing and repairing effects | 上海家化联合股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-112972601-B | Traditional Chinese medicine fermentation product and application thereof in skin external preparation | 上海家化联合股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117597103-A | Compositions comprising AHA and/or BHA stabilized by a combination of mono-or di-alkyl isosorbide, polyethylene glycol-polypropylene glycol ether and two hydrogenated or non-hydrogenated polyoxyethylated vegetable oils | 莱雅公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20240041731-A1 | TWO-PHASE COSMETIC COMPOSITION COMPRISING AN AMINO ACID AND TWO SPECIFIC ACIDS | L'OREAL (FR) | 2024-02-08 | — | — | US | disclosed |
| US-20240041715-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | L'OREAL (FR) | 2024-02-08 | — | — | US | disclosed |
| US-20240033194-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | L'OREAL (FR) | 2024-02-01 | — | — | US | disclosed |
| CN-117427128-A | Composition containing epiphyllum extract and application thereof | 上海家化联合股份有限公司 | 2024-01-23 | — | — | CN | disclosed |
| US-20120003167-A1 | COSMETIC COMPOSITION COMPRISING SILOXANE RESINS AND AT LEAST ONE PHENYL SILICONE OIL | L'OREAL (FR) | 2012-01-05 | — | — | US | disclosed |
| WO-2010106498-A1 | A PACKAGING AND APPLICATOR DEVICE FOR AT LEAST ONE SOLID COSMETIC COMPOSITION | L'OREAL (FR) | 2010-09-23 | — | — | WO | disclosed |
| US-20100031969-A1 | EYELASH MAKEUP AND/OR CARE ASSEMBLY | L'OREAL (FR) | 2010-02-11 | — | — | US | disclosed |
| CN-1229108-C | Use of cosmetics of block ethylene copolymers with elastic character and compositions containing same | OREAL (FR) | 2005-11-30 | — | — | CN | disclosed |
| US-6805872-B2 | INCORPORATING INTO COSMETIC COMPOSITION BLOCK ETHYLENIC COPOLYMER OF ELASTIC NATURE INCLUDING RIGID BLOCK HAVING GLASS TRANSITION TEMPERATURE OF 20 DEGREES C. OR MORE AND FLEXIBLE BLOCK HAVING LOWER GLASS TRANSITION TEMPERATURE | L'OREAL (FR) | 2004-10-19 | — | — | US | disclosed |
| CN-1496733-A | Cosmetic and/or skin applied of composition containing easy oxidation hydrophilic active component stablized by maleic anhydride copolymer | 莱雅公司 | 2004-05-19 | — | — | CN | disclosed |
| CN-1421193-A | Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology | OREAL (FR) | 2003-06-04 | — | — | CN | disclosed |
| CN-1380828-A | Use of elastomeric olefinic block copolymers in cosmetics and compositions containing them | OREAL (FR) | 2002-11-20 | — | — | CN | disclosed |
| US-20020115780-A1 | At least one rigid block having a glass transition temperature (Tg) of greater than or equal to 20 degrees C., and at least one flexible block having a glass transition temperature (Tg) of less than 20 degrees C. | L'OREAL (FR) | 2002-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041715-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | TRPM5, TRPM6, MSH6 | NAAA 673/4885EPHX1 1149/4885TSHR 1959/4885 |
| US-20120003167-A1 | COSMETIC COMPOSITION COMPRISING SILOXANE RESINS AND AT LEAST ONE PHENYL SILICONE OIL | QSOX1, RXRB, PRXL2A | NAAA 4189/4885EPHX1 1130/4885TSHR 1259/4885 |
| US-20100031969-A1 | EYELASH MAKEUP AND/OR CARE ASSEMBLY | KRT18, FLNA, F7 | NAAA 4111/4885EPHX1 3336/4885TSHR 2350/4885 |
| US-20240041731-A1 | TWO-PHASE COSMETIC COMPOSITION COMPRISING AN AMINO ACID AND TWO SPECIFIC ACIDS | SCLY, CUTA, ALAD | NAAA 1284/4885EPHX1 1857/4885TSHR 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.